BR0116558A - Composição farmacêutica em comprimido, base livre de amilodipina, método de tratamento ou prevenção de hipertensão, angina ou congestão cardìaca, processo, processo para purificação de base livre de amlodipina e população base livre de amlodipina em partìculas - Google Patents
Composição farmacêutica em comprimido, base livre de amilodipina, método de tratamento ou prevenção de hipertensão, angina ou congestão cardìaca, processo, processo para purificação de base livre de amlodipina e população base livre de amlodipina em partìculasInfo
- Publication number
- BR0116558A BR0116558A BR0116558-5A BR0116558A BR0116558A BR 0116558 A BR0116558 A BR 0116558A BR 0116558 A BR0116558 A BR 0116558A BR 0116558 A BR0116558 A BR 0116558A
- Authority
- BR
- Brazil
- Prior art keywords
- free base
- amlodipine
- hypertension
- tablet
- purification
- Prior art date
Links
- HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 7
- 206010020772 Hypertension Diseases 0.000 title abstract 2
- 230000000747 cardiac effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 title 1
- 239000012458 free base Substances 0.000 title 1
- 239000002585 base Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25861300P | 2000-12-29 | 2000-12-29 | |
| US80935101A | 2001-03-16 | 2001-03-16 | |
| PCT/NL2001/000947 WO2002053135A1 (en) | 2000-12-29 | 2001-12-31 | Amlodipine free base |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0116558A true BR0116558A (pt) | 2003-10-28 |
Family
ID=26946752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0116558-5A BR0116558A (pt) | 2000-12-29 | 2001-12-31 | Composição farmacêutica em comprimido, base livre de amilodipina, método de tratamento ou prevenção de hipertensão, angina ou congestão cardìaca, processo, processo para purificação de base livre de amlodipina e população base livre de amlodipina em partìculas |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1345901A2 (enExample) |
| AU (1) | AU2001294354A1 (enExample) |
| BR (1) | BR0116558A (enExample) |
| CA (1) | CA2433366C (enExample) |
| CZ (1) | CZ20031779A3 (enExample) |
| DE (2) | DE20116723U1 (enExample) |
| ES (1) | ES2277960T3 (enExample) |
| MX (1) | MXPA03005888A (enExample) |
| WO (2) | WO2002053535A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1014450A6 (nl) * | 2000-12-29 | 2003-10-07 | Bioorg Bv | Werkwijze voor het maken van amlodipine, derivaten daarvan en voorlopers daarvoor. |
| EP1346214A2 (en) | 2000-12-29 | 2003-09-24 | Pfizer Limited | Reference standards and processes for determining the purity or stability of amlodipine maleate |
| US6828339B2 (en) * | 2001-11-21 | 2004-12-07 | Synthon Bv | Amlodipine salt forms and processes for preparing them |
| NL1019882C2 (nl) * | 2002-02-01 | 2003-08-04 | Synthon Licensing | Amlodipine vrije base. |
| ES2211317B1 (es) * | 2002-11-18 | 2005-10-16 | Finaf 92, S.A. | Compuestos intermedios para la obtencion de principios activos antihipertensivos y procedimientos correspondientes. |
| EP1587792B1 (en) * | 2003-01-27 | 2014-08-27 | Hanmi Science Co., Ltd. | Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof |
| WO2004075825A2 (en) * | 2003-02-28 | 2004-09-10 | Ranbaxy Laboratories Limited | Dosage forms of amlodipine and processes for their preparation |
| CH697952B1 (de) * | 2003-07-25 | 2009-03-31 | Siegfried Generics Int Ag | Verfahren zur Reinigung der freien Amlodipinbase. |
| WO2005023769A1 (en) * | 2003-09-04 | 2005-03-17 | Cipla Limited | Process for the preparation of amlodipine salts |
| KR100604034B1 (ko) * | 2003-10-08 | 2006-07-24 | 주식회사유한양행 | 암로디핀 유리염기를 함유한 구강 속붕해정 및 그의 조성물 |
| WO2007131759A1 (en) * | 2006-05-15 | 2007-11-22 | Lek Pharmaceuticals D.D. | A process for the preparation of amlodipine benzenesulfonate |
| EP1975167A1 (en) | 2007-03-30 | 2008-10-01 | Esteve Quimica, S.A. | Acetone solvate of phthaloyl amlodipine |
| WO2011117876A1 (en) | 2010-03-26 | 2011-09-29 | Fdc Limited | An improved process for the preparation of amlodipine free base and acid addition salts thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK161312C (da) * | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
| PL140069B1 (en) | 1982-12-21 | 1987-03-31 | Pfizer | Method of obtaining new derivatives of dihydropiridine |
| DE3544211A1 (de) * | 1985-12-13 | 1987-06-19 | Bayer Ag | Neue, fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE4305454A1 (de) * | 1993-02-23 | 1994-08-25 | Bayer Ag | Klotzverfahren mit einer Phthalocyaninmischung |
| GB9317773D0 (en) * | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
| GB0008332D0 (en) * | 2000-04-04 | 2000-05-24 | Pfizer Ltd | Treament |
| GB0020842D0 (en) * | 2000-08-23 | 2000-10-11 | Pfizer Ltd | Therapeutic compositions |
-
2001
- 2001-08-15 WO PCT/NL2001/000601 patent/WO2002053535A2/en not_active Ceased
- 2001-08-15 CZ CZ20031779A patent/CZ20031779A3/cs unknown
- 2001-08-15 AU AU2001294354A patent/AU2001294354A1/en not_active Abandoned
- 2001-08-15 EP EP01974983A patent/EP1345901A2/en not_active Withdrawn
- 2001-10-04 DE DE20116723U patent/DE20116723U1/de not_active Ceased
- 2001-12-31 CA CA002433366A patent/CA2433366C/en not_active Expired - Fee Related
- 2001-12-31 WO PCT/NL2001/000947 patent/WO2002053135A1/en not_active Ceased
- 2001-12-31 DE DE60125981T patent/DE60125981T2/de not_active Expired - Fee Related
- 2001-12-31 ES ES01995820T patent/ES2277960T3/es not_active Expired - Lifetime
- 2001-12-31 MX MXPA03005888A patent/MXPA03005888A/es active IP Right Grant
- 2001-12-31 BR BR0116558-5A patent/BR0116558A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20031779A3 (cs) | 2004-10-13 |
| MXPA03005888A (es) | 2005-04-19 |
| DE60125981D1 (de) | 2007-02-22 |
| CA2433366A1 (en) | 2002-07-11 |
| DE20116723U1 (de) | 2002-01-17 |
| AU2001294354A1 (en) | 2002-07-16 |
| DE60125981T2 (de) | 2007-10-18 |
| AU2001294354A8 (enExample) | 2005-10-06 |
| WO2002053135A1 (en) | 2002-07-11 |
| WO2002053535A2 (en) | 2002-07-11 |
| EP1345901A2 (en) | 2003-09-24 |
| CA2433366C (en) | 2006-01-24 |
| WO2002053535A3 (en) | 2003-01-23 |
| ES2277960T3 (es) | 2007-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20030951B1 (hr) | Formulacije jednodnevnih doza oksikodona | |
| ATE495154T1 (de) | Pharmazeutische zusammensetzungen, die ccr5- antagonisierende piperazinderivate enthalten | |
| BR9914251A (pt) | Formulações orais de liberação sustentada | |
| EA200000246A1 (ru) | Быстро дезинтегрирующие таблетки метилцеллюлозы | |
| HUP0302131A2 (hu) | Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények | |
| BR0113710A (pt) | Compostos, processo para a preparação e utilização dos mesmos, composição farmacêutica, processo para o tratamento e profilaxia de artrite, enfermidades cardiovasculares, diabetes, insuficiência renal, distúrbios alimentares e obesidade | |
| CA2396159A1 (en) | Novel substituted benzimidazole dosage forms and method of using same | |
| BR9808429A (pt) | Composição farmacêutica e processo para a sua preparação. | |
| BG106095A (bg) | Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици | |
| IS1781B (is) | Ný lyfjablanda sem inniheldur ACE-blokkarann ramipríl og díhýdrópýridín efnasamband | |
| EE05287B1 (et) | Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
| DE60120648D1 (de) | Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung | |
| CO5280073A1 (es) | Composiciones | |
| BR0212778A (pt) | Composições de desintegração intra-oral organolepticamente aceitáveis | |
| HUP0401569A2 (hu) | Amlodipint és atorvastatint tartalmazó gyógyászati készítmények és eljárás az előállításukra | |
| EA200001201A3 (ru) | Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем | |
| NO20031019L (no) | Vedvarende frigivelsesformuleringer av oksymorfon | |
| FI951357L (fi) | Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen | |
| EE200100104A (et) | 5-HT4 agonisti või antagonisti uus peroraalne ravimvorm | |
| DK1073456T3 (da) | Anvendelse af osteoprotegerin til forebyggelse og behandling af kardiovaskulære sygdomme | |
| ATE215817T1 (de) | Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis | |
| DE60102590T2 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| ATE259369T1 (de) | Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen | |
| YU6401A (sh) | Primena eletriptana za izradu leka za prevenciju učestanog javljanja migrene | |
| AR087240A2 (es) | Composiciones farmaceuticas que tienen epinastina y pseudoefedrina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] |
Free format text: DE ACORDO COM O ART.34 "II" DA LPI (LEI 9279, DE 14/05/96), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO. |
|
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |